helicid 40 mg proszek do sporządzania roztworu do infuzji
zentiva, k.s. - omeprazol sodowy - proszek do sporządzania roztworu do infuzji - 40 mg
prialt
esteve pharmaceuticals gmbh - zykonotyd - injections, spinal; pain - Środki przeciwbólowe - zykonotyd jest wskazany w leczeniu ciężkiego, przewlekłego bólu u pacjentów wymagających znieczulenia dooponowego (it).
chorapur 1500 iu proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań
ferring gmbh - gonadotrophinum chorionicum - proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań - 1500 iu
chorapur 5000 iu proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań
ferring gmbh - gonadotrophinum chorionicum - proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań - 5000 iu
sugammadex sandoz 100 mg/ml roztwór do wstrzykiwań
sandoz gmbh - sugammadexum - roztwór do wstrzykiwań - 100 mg/ml
sugammadex stada 100 mg/ml roztwór do wstrzykiwań
stada arzneimittel ag - sugammadexum natricum - roztwór do wstrzykiwań - 100 mg/ml
dacarbazin lipomed 200 mg proszek do sporządzania roztworu do wstrzykiwań lub infuzji
lipomed gmbh - dacarbazinum - proszek do sporządzania roztworu do wstrzykiwań lub infuzji - 200 mg
piperacillin/tazobactam noridem 2 g + 0,25 g proszek do sporządzania roztworu do infuzji
noridem enterprises ltd. - piperacillinum + tazobactamum - proszek do sporządzania roztworu do infuzji - 2 g + 0,25 g
piperacillin/tazobactam noridem 4 g + 0,5 g proszek do sporządzania roztworu do infuzji
noridem enterprises ltd. - piperacillinum + tazobactamum - proszek do sporządzania roztworu do infuzji - 4 g + 0,5 g
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - szczepionki - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. stosowanie tej szczepionki powinno odbywać się zgodnie z oficjalnymi zaleceniami.